OCUL- Ocular Therapeutix, Inc.

Name: Ocular Therapeutix, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Ocular Therapeutix, Inc. (OCUL) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. OCUL is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Other	Dugel Pravin	394.7K	$3.95M	-
Other	Notman Donald	389.3K	$3.90M	-
Other	Nayak Sanjay	330.7K	$3.31M	-
Other	Waheed Nadia	326.3K	$3.27M	-
Other	Heier Jeffrey S.	323.4K	$3.24M	-

Activity

Buys and sells only

Transactions

10 filings · page 2

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Oct 2, 2025	Kaiser Peter	Chief Development Officer	Sell	9,653	$11.03	$106,472.59	-4.7%	+9.8%	-
Oct 2, 2025	Heier Jeffrey S.61	Chief Scientific Officer	Sell	10,502	$11.04	$115,942.08	-4.0%	+9.8%	-
Sep 2, 2025	Notman Donald	See Remarks	Sell	1,066	$12.43	$13,250.38	-0.3%	-7.8%	-
Aug 25, 2025	Kaiser Peter	Chief Development Officer	Sell	3,011	$12.04	$36,252.44	-1.5%	+1.9%	-
Aug 25, 2025	Nayak Sanjay	Chief Strategy Officer	Sell	1,885	$12.04	$22,695.40	-0.7%	+1.9%	-
Aug 25, 2025	Heier Jeffrey S.61	Chief Scientific Officer	Sell	3,063	$12.04	$36,878.52	-1.2%	+1.9%	-
Aug 25, 2025	Dugel Pravin	See Remarks	Sell	21,494	$12.04	$258,787.76	-0.7%	+1.9%	-
Jun 2, 2025	Waheed Nadia	Chief Medical Officer	Sell	13,861	$8.05	$111,581.05	-6.3%	+56.6%	+11.1%
May 23, 2025	Nayak Sanjay	Chief Strategy Officer	Sell	1,862	$7.17	$13,350.54	-0.7%	+66.2%	+12.7%
May 23, 2025	Kaiser Peter	Chief Development Officer	Sell	2,974	$7.17	$21,323.58	-1.4%	+66.2%	+12.7%

← PrevPage 2Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC